other
5-Amino-1MQ tracker
Educational reference for 5-Amino-1MQ. Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
—
Tmax
—
Category
other
Also known as: 5-amino-1-methylquinolinium
5-Amino-1MQ is a research NNMT inhibitor explored for metabolism and fat loss. Not well characterized in humans; not FDA-approved. Taken orally.
Mechanism
A small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). In preclinical research, inhibiting NNMT is associated with changes in NAD+ salvage and cellular metabolism in adipose tissue. Human mechanistic data are limited.
Research summary
Evidence is largely preclinical (cell and rodent studies) exploring metabolic and adipose-tissue effects. It is not an FDA-approved drug, and rigorous human clinical trial data are lacking. Claims should be read against that evidence gap.
Reported side effects
Because controlled human safety data are limited, the side-effect and long-term safety profile is largely unknown. Sourcing and purity are common quality concerns raised in the literature.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- NNMT inhibition and metabolic regulation (preclinical review) · peer-reviewed review article (2018)predominantly animal-model evidence; search PubMed for NNMT inhibitor
- Regulatory status note · FDA / regulatory guidance (2024)not an approved drug; verify current status
Το TrackPep είναι εφαρμογή παρακολούθησης. Καταγράφει όσα καταχωρίζεις και ποτέ δεν προτείνει ούτε υπολογίζει ποσότητες.